Literature DB >> 2309059

[A new method of quantitative analysis of parkinsonian gait: report of 6 patients].

O Blin1, A M Ferrandez, J Pailhous, G Serratrice.   

Abstract

A simple quantitative method of gait analysis in parkinsonism is presented. In this method, spatial and temporal parameters (stride length and duration, stance duration and double support duration) and cinematic parameters (velocity) were evaluated. A pilot trial performed in 6 patients highlighted the pathological aspect of the parkinsonian gait as compared to the gait of healthy elderly subjects. A significant degradation (reduced speed, diminished stride length, short duration of the double support stage) was noted, even when parkinsonians were compared with the oldest of the control subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309059

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  4 in total

1.  Quantitative analysis of walking in patients with knee osteoarthritis: a method of assessing the effectiveness of non-steroidal anti-inflammatory treatment.

Authors:  O Blin; J Pailhous; P Lafforgue; G Serratrice
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

2.  Instability of syllable repetition as a model for impaired motor processing: is Parkinson's disease a "rhythm disorder"?

Authors:  Sabine Skodda; Andrea Flasskamp; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2010-03-18       Impact factor: 3.575

3.  Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.

Authors:  P Vieregge; H Stolze; C Klein; I Heberlein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.

Authors:  Jaime M Hatcher; Jason R Richardson; Thomas S Guillot; Alison L McCormack; Donato A Di Monte; Dean P Jones; Kurt D Pennell; Gary W Miller
Journal:  Exp Neurol       Date:  2007-01-05       Impact factor: 5.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.